As of 2025-12-17, the Relative Valuation of Aldeyra Therapeutics Inc (ALDX) is (7.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.99 USD, the upside of Aldeyra Therapeutics Inc based on Relative Valuation is -288.9%.
The range of the Relative Valuation is (5.44) - (10.24) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 14.3x | 9.7x |
| Forward P/E multiples | 7.6x - 15.0x | 11.3x |
| Fair Price | (5.44) - (10.24) | (7.54) |
| Upside | -236.4% - -356.6% | -288.9% |
| Date | P/E |
| 2025-12-15 | -5.56 |
| 2025-12-12 | -6.32 |
| 2025-12-11 | -6.39 |
| 2025-12-10 | -6.67 |
| 2025-12-09 | -6.67 |
| 2025-12-08 | -6.89 |
| 2025-12-05 | -6.55 |
| 2025-12-04 | -6.80 |
| 2025-12-03 | -6.78 |
| 2025-12-02 | -6.78 |
| 2025-12-01 | -7.30 |
| 2025-11-28 | -7.63 |
| 2025-11-26 | -7.79 |
| 2025-11-25 | -7.33 |
| 2025-11-24 | -7.28 |
| 2025-11-21 | -6.91 |
| 2025-11-20 | -6.59 |
| 2025-11-19 | -6.77 |
| 2025-11-18 | -6.84 |
| 2025-11-17 | -6.89 |
| 2025-11-14 | -7.03 |
| 2025-11-13 | -6.99 |
| 2025-11-12 | -7.38 |
| 2025-11-11 | -7.28 |
| 2025-11-10 | -7.15 |
| 2025-11-07 | -6.53 |
| 2025-11-06 | -6.70 |
| 2025-11-05 | -6.87 |
| 2025-11-04 | -6.85 |
| 2025-11-03 | -7.28 |
| 2025-10-31 | -7.06 |
| 2025-10-30 | -7.01 |
| 2025-10-29 | -7.04 |
| 2025-10-28 | -7.16 |
| 2025-10-27 | -7.28 |
| 2025-10-24 | -7.30 |
| 2025-10-23 | -7.21 |
| 2025-10-22 | -7.23 |
| 2025-10-21 | -7.67 |
| 2025-10-20 | -7.58 |
| 2025-10-17 | -7.33 |
| 2025-10-16 | -7.51 |
| 2025-10-15 | -7.88 |
| 2025-10-14 | -7.44 |
| 2025-10-13 | -7.31 |
| 2025-10-10 | -7.51 |
| 2025-10-09 | -7.90 |
| 2025-10-08 | -7.83 |
| 2025-10-07 | -7.81 |
| 2025-10-06 | -7.67 |